Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.19NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.19NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.18NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.18NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.404NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-18259.5US
B.1.1.404NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.404NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-15848China
CV.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CV.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CV.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DJ.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DJ.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DJ.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.73NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.73NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.73NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DW.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DW.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BR.5.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BR.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BR.5.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.75.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.75.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.75.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAKNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAKNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAKNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAANUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAANYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.42.1 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.42.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.42.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.348NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.348NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.348NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.428.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.428.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.428.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AJ.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AJ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.459NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.459NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.459NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160.29NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.160.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.29NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used